Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1921-1930 of 2869 for cancer

Edit search filters
  1. A Study To Evaluate The Long-Term Safety And Effectiveness Of Caplacizumab For Patients Who Completed Study ALX0681-C301

    Rochester, MN

  2. In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells

    Rochester, MN

  3. A Study to Evaluate the Pharmacokinetics of Low-Dose Bevacuzimab in Reducing Free Plasma VEGF-A in Hemodialysis Patients

    Rochester, MN

  4. A Phase 2 Trial Of AMI MultiStem® Therapy In Subjects With Non-ST Elevation Acute Myocardial Infarction

    Scottsdale/Phoenix, AZ

  5. 24-Week Study To Assess The PD, Safety, Tolerability, And PK Of GLM101 In Adults With PMM2-CDG

    Rochester, MN

  6. A Safety Study Of SYNT001 In Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA)

    Rochester, MN

  7. PAC203: A Randomized, Controlled Phase 3 Study Of Pacritinib Versus Physician’s Choice In Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Or Post Essential Thrombocythemia Myelofibrosis With Severe Thrombocytopenia (Platelet Counts <50,000 _l29_="" />

    Scottsdale/Phoenix, AZ

  8. Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation

    Rochester, MN

  9. Endoscopic Mucosal Resection And Cellular Matrix

    Rochester, MN

  10. Ixazomib Citrate, Lenalidomide, And Dexamethasone In Treating Patients With POEMS Syndrome

    Rochester, MN

.

Mayo Clinic Footer